M Kasai

FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.

A Kanamaru, Y Takemoto, Eizo Kakishita et al. · PubMed · 1995 · 54 citations

Pharmacy, Immunology, Pharmacotherapy +17

Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death

A Kohno, Nobuhiko Emi, M Kasai et al. · Gene Therapy · 1998 · 47 citations

Life Sciences, Biotechnology, Molecular Biology +14

Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations

Tomohiro Aoki, Yoshihisa Harada, E. Matsubara et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 24 citations

Medicine, Hematology, Pharmacology +15

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies

Sho Yamasaki, Yoshinori Ohno, Shuichi Taniguchi et al. · Bone Marrow Transplantation · 2003 · 16 citations

Medicine, Hematology, Immunology +16

CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma.

Nobuhiko Emi, A Abe, M Kasai et al. · PubMed · 1999 · 10 citations

Life Sciences, Cell Biology, Hematology +14